Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP
Holding TTNP?
Track your performance easily
TTNP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.24 - $14.80
Previous Close$5.77
Volume11.13K
Average Volume (3M)457.38K
Market Cap
$5.28M
Enterprise Value$1.18M
Total Cash (Recent Filing)$4.09M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Nov 11, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.50
Shares Outstanding914,234
10 Day Avg. Volume83,506
30 Day Avg. Volume457,377
Standard Deviation0.25
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.32
Price to Sales (P/S)5055.71
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue13.60
Enterprise Value/Gross Profit1.18K
Enterprise Value/Ebitda-0.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Titan Pharmaceuticals News
PremiumCompany Announcements
Titan Pharmaceuticals Embarks on Strategic Merger and Restructuring
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TTNP FAQ
What was Titan Pharmaceuticals’s price range in the past 12 months?
Titan Pharmaceuticals lowest stock price was $4.24 and its highest was $14.80 in the past 12 months.
What is Titan Pharmaceuticals’s market cap?
Currently, no data Available
When is Titan Pharmaceuticals’s upcoming earnings report date?
Titan Pharmaceuticals’s upcoming earnings report date is Nov 11, 2024 which is in 52 days.
How were Titan Pharmaceuticals’s earnings last quarter?
Titan Pharmaceuticals released its earnings results on Nov 13, 2023. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.022.
Is Titan Pharmaceuticals overvalued?
According to Wall Street analysts Titan Pharmaceuticals’s price is currently Overvalued.
Does Titan Pharmaceuticals pay dividends?
Titan Pharmaceuticals does not currently pay dividends.
What is Titan Pharmaceuticals’s EPS estimate?
Titan Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Titan Pharmaceuticals have?
Titan Pharmaceuticals has 914,234 shares outstanding.
What happened to Titan Pharmaceuticals’s price movement after its last earnings report?
Titan Pharmaceuticals reported an EPS of -$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.032%.
Which hedge fund is a major shareholder of Titan Pharmaceuticals?
Currently, no hedge funds are holding shares in TTNP
---
Titan Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.91%
12-Months-Change
Fundamentals
Return on Equity
-368.99%
Trailing 12-Months
Asset Growth
435.71%
Trailing 12-Months
Company Description
Titan Pharmaceuticals
Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.
---
Technical Analysis
---